T-cell contact-dependent regulation of CC and CXC chemokine production in monocytes through differential involvement of NFκB:: implications for rheumatoid arthritis

被引:34
作者
Beech, Jonathan T.
Andreakos, Evangelos
Ciesielski, Cathleen J.
Green, Patricia
Foxwell, Brian M. J.
Brennan, Fionula M.
机构
[1] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol Div, Sch Med, London W6 8LH, England
[2] Acad Athens, Fdn Biomed Res, Ctr Immunol & Transplantat, Athens 11527, Greece
关键词
D O I
10.1186/ar2077
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We and others have reported that rheumatoid arthritis (RA) synovial T cells can activate human monocytes/macrophages in a contact-dependent manner to induce the expression of inflammatory cytokines, including tumour necrosis factor alpha (TNF alpha). In the present study we demonstrate that RA synovial T cells without further activation can also induce monocyte CC and CXC chemokine production in a contact-dependent manner. The transcription factor NF kappa B is differentially involved in this process as CXC chemokines but not CC chemokines are inhibited after overexpression of I kappa B alpha, the natural inhibitor of NF kappa B. This effector function of RA synovial T cells is also shared by T cells activated with a cytokine cocktail containing IL-2, IL-6 and TNF alpha, but not T cells activated by anti-CD3 cross-linking that mimics TCR engagement. This study demonstrates for the first time that RA synovial T cells as well as cytokine-activated T cells are able to induce monocyte chemokine production in a contact-dependent manner and through NF kappa B-dependent and NF kappa B-independent mechanisms, in a process influenced by the phosphatidyl-inositol-3-kinase pathway. Moreover, this study provides further evidence that cytokine-activated T cells share aspects of their effector function with RA synovial T cells and that their targeting in the clinic has therapeutic potential.
引用
收藏
页数:10
相关论文
共 53 条
  • [1] The toll-like receptor-nuclear factor κB pathway in rheumatoid arthritis
    Andreakos, E
    Sacre, S
    Foxwell, BM
    Feldmann, M
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 : 2478 - 2488
  • [2] Heterogeneous requirement of IκB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis -: Implications for therapy
    Andreakos, E
    Smith, C
    Kiriakidis, S
    Monaco, C
    de Martin, R
    Brennan, FM
    Paleolog, E
    Feldmann, M
    Foxwell, BM
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (07): : 1901 - 1912
  • [3] Cytokines and anti-cytokine biologicals in autoimmunity: present and future
    Andreakos, ET
    Foxwell, BM
    Brennan, FM
    Maini, RN
    Feldmann, M
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (4-5) : 299 - 313
  • [4] Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases
    Barnes, PJ
    Larin, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) : 1066 - 1071
  • [5] Bondeson J, 1999, J IMMUNOL, V162, P2939
  • [6] Brennan FM, 2002, ARTHRITIS RHEUM, V46, P31, DOI 10.1002/1529-0131(200201)46:1<31::AID-ART10029>3.0.CO
  • [7] 2-5
  • [8] DETECTION OF INTERLEUKIN-8 BIOLOGICAL-ACTIVITY IN SYNOVIAL-FLUIDS FROM PATIENTS WITH RHEUMATOID-ARTHRITIS AND PRODUCTION OF INTERLEUKIN-8 MESSENGER-RNA BY ISOLATED SYNOVIAL-CELLS
    BRENNAN, FM
    ZACHARIAE, COC
    CHANTRY, D
    LARSEN, CG
    TURNER, M
    MAINI, RN
    MATSUSHIMA, K
    FELDMANN, M
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (09) : 2141 - 2144
  • [9] Burger D, 1998, ARTHRITIS RHEUM, V41, P1748, DOI 10.1002/1529-0131(199810)41:10<1748::AID-ART7>3.3.CO
  • [10] 2-V